PAM
GNMK

Panagora Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Panagora Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-120,982
Closed -$2.89M – 3167
2021
Q1 		$2.89M Sell
120,982
-158,501
-57% -$2.95M 0.02% 620
2020
Q4 		$4.08M Buy
279,483
+111,328
+66% +$1.48M 0.02% 477
2020
Q3 		$2.39M Buy
168,155
+14,207
+9% +$217K 0.02% 571
2020
Q2 		$2.27M Buy
153,948
+81,006
+111% +$823K 0.01% 621
2020
Q1 		$300K Sell
72,942
-111,841
-61% -$524K ﹤0.01% 1323
2019
Q4 		$889K Sell
184,783
-42,806
-19% -$236K ﹤0.01% 1097
2019
Q3 		$1.38M Buy
227,589
+177,782
+357% +$1.11M 0.01% 893
2019
Q2 		$323K Buy
+49,807
New +$351K ﹤0.01% 1601
2013
Q3 		– Sell
-42,605
Closed -$441K – 2389
2013
Q2 		$441K Buy
+42,605
New +$587K ﹤0.01% 1354

Panagora Asset Management's GNMK Position: Q2 2021 in Review

Panagora Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 120,982 shares — an estimated $2.89M sold.

Panagora Asset Management first reported a position in GNMK in Q2 2013 and held it in 9 quarters. The position peaked at $4.08M in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Panagora Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 120,982 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $2.89M.
  • Panagora Asset Management first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 9 quarters.
  • Panagora Asset Management's GenMark Diagnostics, Inc position peaked at $4.08M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.